PT Brigit Biofarmaka Technologi Tbk (IDX:OBAT)
Indonesia flag Indonesia · Delayed Price · Currency is IDR
336.00
+2.00 (0.60%)
At close: Apr 9, 2026

IDX:OBAT Income Statement

Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21
145,913120,62756,93038,49637,853
Revenue Growth (YoY)
34.73%111.89%47.89%1.70%-
Cost of Revenue
79,33664,20634,57819,02214,872
Gross Profit
66,57756,42122,35219,47422,981
Selling, General & Admin
23,89418,5327,7515,7524,498
Other Operating Expenses
1,456110.2694.21110.23188.84
Operating Expenses
25,35018,6437,8455,8624,687
Operating Income
41,22737,77814,50713,61118,294
Interest Expense
-1,038-1,381-1,253-845.28-279.34
Interest & Investment Income
608.572,6741,8221,369750.66
Earnings From Equity Investments
467.48406.25-250.26--
Other Non Operating Income (Expenses)
40.2152.54-1.45-2.611.74
EBT Excluding Unusual Items
41,30539,53114,82414,13318,767
Asset Writedown
--3.83-66.98-2.97-7.76
Other Unusual Items
--337.11816.75731.4
Pretax Income
41,28339,52715,09414,94619,491
Income Tax Expense
7,5339,0283,1863,3224,184
Earnings From Continuing Operations
33,75030,49911,90811,62515,307
Minority Interest in Earnings
-4,809-1,07365.94759.76342.69
Net Income
28,94129,42611,97412,38415,649
Net Income to Common
28,94129,42611,97412,38415,649
Net Income Growth
18.19%145.75%-3.32%-20.86%-
Shares Outstanding (Basic)
600600430463463
Shares Outstanding (Diluted)
600600430463463
Shares Change (YoY)
34.38%39.53%-7.13%--
EPS (Basic)
48.2449.0427.8526.7533.80
EPS (Diluted)
48.2449.0427.8526.7533.80
EPS Growth
-12.04%76.12%4.10%-20.86%-
Free Cash Flow
-12,3036,3556,5287,14814,908
Free Cash Flow Per Share
-20.5010.5915.1815.4432.20
Dividend Per Share
22.37022.37016.95032.40017.280
Dividend Growth
31.98%31.98%-47.69%87.50%-
Gross Margin
45.63%46.77%39.26%50.59%60.71%
Operating Margin
28.26%31.32%25.48%35.36%48.33%
Profit Margin
19.83%24.39%21.03%32.17%41.34%
Free Cash Flow Margin
-8.43%5.27%11.47%18.57%39.38%
EBITDA
43,49839,97416,58214,87519,026
EBITDA Margin
29.81%33.14%29.13%38.64%50.26%
D&A For EBITDA
2,2702,1962,0751,263731.94
EBIT
41,22737,77814,50713,61118,294
EBIT Margin
28.26%31.32%25.48%35.36%48.33%
Effective Tax Rate
18.25%22.84%21.11%22.23%21.47%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.